Evaluation of Bone Turnover Markers Such as Osteoprotegerin, Sclerostin and Dickkopf-1 in Subclinical Hyperthyroidism-Reference-Cited by-同舟云学术

Evaluation of Bone Turnover Markers Such as Osteoprotegerin, Sclerostin and Dickkopf-1 in Subclinical Hyperthyroidism

Published:2022-09-06 Issue: Volume: Page:
ISSN:0970-1915
Container-title:Indian Journal of Clinical Biochemistry
language:en
Short-container-title:Ind J Clin Biochem

Author:

Özbek Ayşe Elverdi^ORCID,Korkmaz Hüseyin^ORCID,Sözen Mehmet^ORCID,İpekçi Süleyman Hilmi^ORCID,Abuşoğlu Sedat^ORCID,Kıraç Cem Onur^ORCID,Ünlü Ali^ORCID,Kebapçılar Levent^ORCID

Funder

Selçuk University Research Foundation

Publisher

Springer Science and Business Media LLC

Subject

Clinical Biochemistry

Link

https://link.springer.com/content/pdf/10.1007/s12291-022-01080-6.pdf

Reference20 articles.

1. Vestergaard P, Mosekilde L. Hyperthyroidism, bone mineral, fracture risk - A meta-analysis. Thyroid [Internet]. Mary Ann Liebert Inc.; 2003 [cited 2020 Dec 13];13:585–93. Available from: https://www.liebertpub.com/doi/abs/10.1089/105072503322238854.

2. Abe E, Marians RC, Yu W, Wu X, Bin, Ando T, Li Y, et al. TSH is a negative regulator of skeletal remodeling. Cell Cell Press. 2003;115:151–62.

3. Baron R, Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med [Internet]. 2013 [cited 2020 Dec 14];19:179–92. Available from: http://www.nature.com/articles/nm.3074.

4. Cooper DS, Biondi B. Subclinical thyroid disease. Lancet. Elsevier; 2012. p. 1142–54.

5. Blum MR, Bauer DC, Collet TH, Fink HA, Cappola AR, Da Costa BR, et al. Subclinical thyroid dysfunction and fracture risk a meta-analysis. JAMA - J Am Med Assoc [Internet]. American Medical Association; 2015 [cited 2020 Dec 14];313:2055–65. Available from: https://jamanetwork.com/.